Bausch + Lomb Corporation (BLCO)
$17.30+0.87%Close
SELLBEAR · day 21
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $6.2B
- Beta
- 0.56
- P/E (TTM)
- -35.93
- Short % float
- 6.59%
- Days to cover
- 9.8
- SI change
- -6.5%
- 1W
- +1.11%
- 1M
- -1.42%
- vs SPY 1W
- -0.05%
- vs SPY 1M
- -4.42%
Industry peers
FMP comparable companies · ranked by market cap
- PCVXBUYVaxcyte, Inc.$10.3BRECOVERYQ 26$71.38+9.78%
- GKOSSELLGlaukos Corporation$9.8BRECOVERYQ 19$165.69+2.73%
- ARWRSELLArrowhead Pharmaceuticals, Inc.$8.8BCRISISQ 12$62.75+3.31%
- OSCRBUYOscar Health, Inc.$8.7BBULLQ 11$33.37+0.82%
- TGTXSELLTG Therapeutics, Inc.$8.5BBEARQ 11$55.37+3.81%
- ACLXArcellx, Inc.$6.7B$115.07
- TFXSELLTeleflex Incorporated$5.5BBEARQ 11$125.12+0.75%
- PTCTSELLPTC Therapeutics, Inc.$5.4BRECOVERYQ 18$64.70+3.42%
- MMSISELLMerit Medical Systems, Inc.$5.2BBEARQ 13$87.21+2.30%
- CRSPSELLCRISPR Therapeutics AG$5.1BBEARQ 20$53.39+5.85%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on BLCO?
- LOPJLB’s latest quantitative signal on Bausch + Lomb Corporation (BLCO) is SELL in a BEAR regime. Signals are updated daily.
- What market regime is BLCO in?
- Bausch + Lomb Corporation (BLCO) is currently classified in the BEAR HMM market regime on LOPJLB.
- What does Bausch + Lomb Corporation (BLCO) do?
- Bausch + Lomb Corporation is a leading global eye health company. Its operations are structured across three primary segments: Vision Care/Consumer Health, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care/Consumer Health division offers a comprehensive portfolio of contact lenses, encompassing all wearing modalities from daily disposables to frequently replaced options. This segment al…